
Real-world data (RWD) overcame the COVID-19 restrictions placed on entering hospitals
09 August 2022
- The digital options of real-world data mean that you can still access the right patient population with the right study design
- RWD is on an adoption curve and being increasing utilised to help pharma companies accelerate medical product development and provide new therapies to patients more efficiently in a very cost-efficient manner
- RWD increases patient diversity in clinical trials, expands indications of already approved drugs, provides an external comparator arm in place of placebo and can help pharmaceutical companies make informed decision